Zafirlukast 20 mg Tablet
Zafirlukast 20 mg Tablet
Zafirlukast 20 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Leukotriene Receptor Antagonist (LTRA) — Antiasthmatic
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Zafirlukast 20 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Prophylaxis and long-term treatment of chronic asthma
- Add-on therapy when asthma is not controlled by inhaled corticosteroids
Mechanism of Action
Zafirlukast competitively blocks cysteinyl leukotriene (CysLT1) receptors in the airways. This reduces bronchoconstriction, airway oedema, mucus secretion and inflammatory cell recruitment triggered by leukotrienes.
Dosage & Administration
- Dosage of Zafirlukast 20 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Headache
- Nausea or stomach upset
- Respiratory infections
- Raised liver enzymes
Contraindications
- Not for relief of acute asthma attacks
- Hepatic impairment; stop if signs of liver injury occur
- Increases warfarin effect; monitor INR
- Eosinophilic conditions may emerge when oral steroids are reduced
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Zafirlukast Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Zafirlukast 20 mg. It is a leukotriene receptor antagonist, used for prophylaxis and long-term treatment of chronic asthma and add-on therapy when asthma is not controlled by inhaled corticosteroids. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Zafirlukast Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Zafirlukast Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Zafirlukast Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Zafirlukast Tablet used for?
Zafirlukast Tablet is used for prophylaxis and long-term treatment of chronic asthma; add-on therapy when asthma is not controlled by inhaled corticosteroids. It should be used as advised by a registered medical practitioner.
Is Zafirlukast Tablet available for PCD pharma franchise on monopoly basis?
Yes. Zafirlukast 20 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Zafirlukast for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Zafirlukast Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Zafirlukast Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Zafirlukast?
Zafirlukast is a leukotriene receptor antagonist (therapeutic class: Leukotriene Receptor Antagonist (LTRA) — Antiasthmatic).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Zafirlukast Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Zafirlukast 20 mg Tablet?